论文部分内容阅读
目的观察参一胶囊防治中晚期食管癌化疗毒副反应的作用。方法将接受化疗的食管癌住院患者随机分为两组,治疗组予化疗加参一胶囊口服,对照组单纯化疗。结果治疗组完成化疗率高于对照组;治疗组患者体重、食欲增加,而患者恶心呕吐、疼痛、乏力、气短、心悸、白细胞下降、心电图发生改变等方面均低于对照组。结论食管癌患者在接受化疗时配合参一胶囊不仅对化疗具有增效减毒作用,同时可以提高患者的生活质量,保护患者的心功能等。
Objective To observe the effect of Shenyi Capsule on the prevention and treatment of chemotherapy-induced side effects of advanced esophageal cancer. Methods Inpatients with esophageal cancer undergoing chemotherapy were randomly divided into two groups: the treatment group received chemotherapy plus Shenyi capsule orally, and the control group received chemotherapy alone. Results The rate of complete chemotherapy in the treatment group was higher than that in the control group. The body weight and appetite of the treatment group were significantly higher than those of the control group in patients with nausea, vomiting, pain, fatigue, shortness of breath, palpitation, leukopenia and electrocardiogram changes. Conclusions Esophageal cancer patients receiving chemotherapy not only have the synergistic effect of reducing toxicity but also improve the quality of life of patients and protect their cardiac function.